Immune evolution from preneoplasia to invasive lung adenocarcinomas and underlying molecular features
Hitoshi Dejima(Osaka City General Hospital), Jianjun Zhang(The University of Texas MD Anderson Cancer Center)
Cited by 17
Related Papers
Comprehensive T cell repertoire characterization of non-small cell lung cancer
|Nature Communications|2020|228
Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study
|The Lancet Digital Health|2023|108
Cross-Site Concordance Evaluation of Tumor DNA and RNA Sequencing Platforms for the CIMAC-CIDC Network
|Clinical Cancer Research|2020|15